A growing body of research suggests that regularly eating this affordable protein may lower Alzheimer's disease risk.
The FDA has approved Auvelity as the first non-antipsychotic treatment for agitation in Alzheimer's disease, marking a major ...
Clinical Trials Arena on MSN
Biogen forges on with Alzheimer’s therapy development despite Phase II miss
The anti-tau therapy demonstrated the strongest efficacy signal at the low 60mg Q6M dose.
Zacks Investment Research on MSN
BIIB advances Alzheimer's disease drug despite study missing main goal
Shares of Biogen BIIB declined more than 6% yesterday after the company announced that it would move its experimental ...
As millions of Americans are living with Alzheimer’s dementia, two researchers spoke with GBH's Morning Edition to break down ...
Natalie Morales opened up to PEOPLE and reflected on her late mother-in-law’s Alzheimer’s diagnosis and its impact on her ...
A healthy brain may help protect thinking and memory skills from the early effects of Alzheimer's disease, a new study has ...
Cochrane review says amyloid-targeting Alzheimer's drugs are ineffective, but the Alzheimer's Association and drug makers ...
Julia Louis-Dreyfus is opening up about the heartbreaking impact Alzheimer’s disease has had on her family. During a Thursday ...
New research suggests eating one simple type of protein may lower the risk of Alzheimer’s disease. This isn’t the first study to make the connection. Experts say there could be a few reasons for this.
After doubling sales of its Biogen-partnered Alzheimer’s disease med Leqembi in its 2025 fiscal year, Eisai figures the crawl to its blockbuster ambitions will hit a stride in 2026, when it expects | ...
The actor-producer opens up to PEOPLE about ‘Tangles,’ which follows a woman navigating her mother's Alzheimer's disease ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results